iMD Companies and Its Subsidiary, Riize Health, Announce New Verticals With White Label and Licensing
IMD Companies (OTC:ICBU) and its subsidiary Riize Health have announced the launch of their white label program and technology licensing verticals, which began on November 26, 2024. The company believes this expansion will enhance their market share, branding, and bottom line by bringing their technology to a broader customer base.
Riize Health operates as a telemedicine/pharmacy services provider, specializing in men's and women's sexual health and weight loss through a revolutionary delivery system. The platform connects patients with licensed healthcare providers through video or phone calls for remote consultations, diagnoses, and personalized treatment plans.
IMD Companies (OTC:ICBU) e la sua sussidiaria Riize Health hanno annunciato il lancio del loro programma in white label e delle verticali di licenza tecnologica, iniziato il 26 novembre 2024. L'azienda crede che questa espansione migliorerà la loro quota di mercato, il branding e il risultato finanziario portando la loro tecnologia a un'utenza più ampia.
Riize Health opera come fornitore di servizi di telemedicina/farmacia, specializzandosi nella salute sessuale degli uomini e delle donne e nella perdita di peso attraverso un sistema di distribuzione rivoluzionario. La piattaforma connette i pazienti con professionisti sanitari autorizzati tramite video o chiamate telefoniche per consultazioni remote, diagnosi e piani di trattamento personalizzati.
IMD Companies (OTC:ICBU) y su subsidiaria Riize Health han anunciado el lanzamiento de su programa de marca blanca y verticales de licencias tecnológicas, que comenzó el 26 de noviembre de 2024. La empresa cree que esta expansión mejorará su participación en el mercado, la marca y los resultados financieros al llevar su tecnología a una base de clientes más amplia.
Riize Health opera como proveedor de servicios de telemedicina/farmacia, especializándose en la salud sexual de hombres y mujeres y en la pérdida de peso a través de un sistema de entrega revolucionario. La plataforma conecta a los pacientes con proveedores de atención médica licenciados a través de video o llamadas telefónicas para consultas remotas, diagnósticos y planes de tratamiento personalizados.
IMD Companies (OTC:ICBU)와 그 자회사 Riize Health가 2024년 11월 26일에 화이트 라벨 프로그램과 기술 라이센스 수직 시장 출시를 발표했습니다. 회사는 이러한 확장이 시장 점유율, 브랜드 및 수익을 향상시킬 것이라고 믿으며, 그들의 기술을 더 넓은 고객 기반에 제공할 것입니다.
Riize Health는 남성과 여성의 성 건강 및 체중 감량을 전문으로 하는 원격 진료/약국 서비스 제공업체로 운영됩니다. 이 플랫폼은 환자와 인증된 의료 제공자를 비디오 또는 전화 통화를 통해 연결하여 원격 상담, 진단 및 개인화된 치료 계획을 제공합니다.
IMD Companies (OTC:ICBU) et sa filiale Riize Health ont annoncé le lancement de leur programme de marque blanche et de leurs verticales de licence technologique, qui a débuté le 26 novembre 2024. L'entreprise estime que cette expansion améliorera sa part de marché, sa notoriété de marque et ses résultats financiers en rendant sa technologie accessible à une base de clients plus large.
Riize Health opère en tant que fournisseur de services de télémédecine/pharmacie, se spécialisant dans la santé sexuelle des hommes et des femmes ainsi que dans la perte de poids via un système de livraison révolutionnaire. La plateforme connecte les patients avec des professionnels de santé agréés par le biais d'appels vidéo ou téléphoniques pour des consultations à distance, des diagnostics et des plans de traitement personnalisés.
IMD Companies (OTC:ICBU) und ihre Tochtergesellschaft Riize Health haben den Start ihres White-Label-Programms und der Technologielizenzierungsbereiche bekannt gegeben, der am 26. November 2024 begann. Das Unternehmen ist der Meinung, dass diese Expansion ihren Marktanteil, ihre Markenbekanntheit und die finanzielle Grundlage verbessern wird, indem sie ihre Technologie einer breiteren Kundenbasis zugänglicher macht.
Riize Health fungiert als Anbieter von Telemedizin- und Apothekendiensten und spezialisiert sich auf die sexuelle Gesundheit von Männern und Frauen sowie auf Gewichtsreduktion durch ein revolutionäres Liefersystem. Die Plattform verbindet Patienten mit lizenzierten Gesundheitsdienstleistern durch Video- oder Telefonanrufe für Fernkonsultationen, Diagnosen und personalisierte Behandlungspläne.
- Launch of new white label program and technology licensing verticals
- Potential for increased revenue through expanded market reach
- Strategic expansion of brand and technology distribution channels
- None.
RANCHO CORDOVA, Calif., Dec. 05, 2024 (GLOBE NEWSWIRE) -- IMD Companies, Inc. (OTC:ICBU) and its subsidiary, Riize LLC (Riize Health), is pleased to announce the launch of our white label and licensing verticals.
On Friday, November 26, 2024, Riize Health began pushing our white label program and licensing of our technology which allows us to expand our market share and branding.
There has been many inquiries about this avenue and we’ve been dissecting what it means to us in the long run and ICBU with its subsidiary has determined the benefits far greater than not doing it. It is our belief that by expanding our brand this way adds multiple facets to our bottom line.
By following many industry standards, we’re going down this path to bring our brand to the forefront as an industry disrupter and innovator. This brings forth many different types of customers to us and expands our awareness to the point of ICBU becoming the company to model after.
"We're excited about these verticals to bring something truly unique to this market and build and provide new products and opportunities," states Reilly Schueler, CEO of Riize Health. "We feel this brings our technology to light and desire for our industry-leading technology to be implemented in an unlimited fashion. Again, we’re just getting started and look forward to giving our clients state-of-the-art delivered products."
Rick Wilson, President and CEO of IMD Companies, Inc., states, "Adding this type of white label and licensing verticals to our already industry-leading technology gives us a major advantage to increase revenue."
Follow Riize Social Media
Website @ https://www.riizehealth.com
Canada @ ca.riizehealth.com
Facebook @ https://www.facebook.com/riizehealth
Instagram @ https://www.instagram.com/riizehealth/
Tiktok @ https://www.tiktok.com/@riize_up_llc
Blogs @ https://riizehealth.com/pages/recent-blog-post
About Riize, LLC
Riize is revolutionizing the healthcare industry as a leading telemedicine/pharmacy services provider. Our specialized focus on men’s and women’s sexual health and weight loss sets us apart from the competition due to our revolutionary delivery system. We are proud to offer a convenient and innovative online healthcare service that connects individuals with licensed healthcare providers. At Riize, we understand the importance of personalized care. That’s why we provide a platform where patients can easily consult with healthcare professionals remotely. Through video or phone calls, individuals can discuss their symptoms, receive accurate diagnoses, and obtain personalized treatment plans that address their specific needs. We believe in breaking down barriers to healthcare access. With Riize, patients no longer have to endure long wait times or travel to a physical clinic. Our user-friendly platform ensures that quality healthcare is just a few clicks away. Join us in shaping the future of healthcare. Experience the convenience and expertise that Riize offers. Your health and well-being are our priorities.
Follow iMD Companies, Inc. Social Media
Twitter @ https://twitter.com/imd_inc
Instagram @ https://www.instagram.com/imdcompaniesinc/
About iMD Companies, Inc.
iMD Companies, Inc. (OTC:ICBU) is a Florida Corporation. The company has been re-positioned to be a holding company for acquisitions and technology development in the healthcare markets. iMD's goal is to combine the expertise of our team members to create a cohesive force, which will carry the company forward in the marketplace.
Safe Harbor Statement
Certain statements made in this press release constitute forward-looking statements that are based on management's expectations, estimates, projections and assumptions. Words such as "expects," "anticipates," "plans," "believes," "scheduled," "estimates" and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements are not guarantees of future performance and involve certain risks and uncertainties, which are difficult to predict. Therefore, actual future results and trends may differ materially from what is forecast in forward-looking statements due to a variety of factors. All forward-looking statements speak only as of the date of this press release and the company does not undertake any obligation to update or publicly release any revisions to forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.
Contact:
iMD Companies, Inc.
info@imdcompaniesinc.com
FAQ
When did IMD Companies (ICBU) launch its white label program?
What services does Riize Health, ICBU's subsidiary, provide?
What are the new verticals announced by ICBU and Riize Health?
